Nami Surgical secures investment for new miniaturised ultrasonic scalpel

Image caption: Nami Surgical's Nico Fenu (CEO and Co-founder) and Dr Rebecca Cleary (CTO and Co-founder)

Scotland-based Nami Surgical has secured $4 million of investment and grant funding. St Andrews-based impact investment firm Eos Advisory (Eos) led the seed $3.1 million round alongside the Investment Fund for Scotland, which is managed by UK private equity firm Maven and delivered by British Business Bank, Scottish Enterprise, and SIS Ventures, while the company was separately awarded a grant from Innovate UK, the United Kingdom’s national innovation agency.

Nami Surgical develops miniaturised ultrasonic medical devices for surgical applications and supports medical device companies to deliver innovation in ultrasonic surgery. In a new development, Nami has introduced a high-performance, miniaturised ultrasonic scalpel, overcoming significant barriers in robotic-assisted surgery.

Traditionally favoured in laparoscopic procedures, ultrasonic scalpels have been too large for effective use in robotic surgery until now. With Nami’s pioneering technology, the integration of ultrasonic scalpels in robotic surgeries sets a new benchmark in surgical care, promising improved outcomes for patients worldwide.